Paper - WANFANG MED ONLINE

You Position: Home > Paper

Classified treatment for irritable bowel syndrome

( views:236, downloads:4 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 7

DOI:: 10.3969/j.issn.1009-3079.2001.07.028

Key Word:: 结肠疾病,功能性/分类;结肠疾病,功能性/治疗

Abstract： @@肠易激综合征(irritable bowel syndrome, IBS)是一种常见的慢性功能性肠道疾病[1-10],其特征是大便习惯和性状的改变、腹痛、腹胀而无器质性病理改变[11-16].在肠易激综合征的流行程度上女性与男性相比有明显的不同.在美国家庭调查[17]中,肠易激综合征存在于14.5%的女性,而在男性仅为7.7%.相似的流行病学上的差别在其他西方国家的研究中也有报道[18-20].在我国,IBS患者占消化专科门诊的比例竟高达20%～50%[21].目前,IBS的各种诊断方法是以症状为基础的[22,23 ],并不评估疾病的严重性,故不能对IBS的治疗策略提供充分的帮助[24-28].为此Drossman et al[29]根据疾病的临床特征将IBS患者分为轻、中、重三类(表1).

Reference

[1]李红梅,梁浩.肠易激综合征的研究进展[J].1998,(2).
[2]N W, Read.Harnessing the patient's powers of recovery: the role of the psychotherapies in the irritable bowel syndrome.[J].1999,13.
[3]T, Wittmann,A, Fehér,A, Rosztóczy,etc.[Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].[J].1999,140(9).
[4]J, Svedlund.Psychotherapy in irritable bowel syndrome. A controlled outcome study.[J].1983,306.
[5]Lin Y,Yuan R.Traditional Chinese medicine: an approach to scientific proof and clinical validation.[J].2000,86(2).
[6]S, Appel,A, Kumle,R, Meier.Clinical pharmacodynamics of SDZ HTF 919, a new 5-HT4 receptor agonist, in a model of slow colonic transit.[J].1997,62.
[7]W G, Thompson.Irritable bowel syndrome: a management strategy.[J].1999,13(3).
[8]Maxwell, P.R.,Mendall, M.A..Irritable bowel syndrome.[J].1997,350(9092).
[9]Camilleri,M.Therapeutic approach to the patient with irritable bowel syndrome.[J].1999,107(5A).
[10]G, Battaglia,A M, Morselli-Labate,E, Camarri,etc.Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study.[J].1998,12(10).
[11]P.J. Whorwell.Hypnotherapy in Irritable Bowel Syndrome[J].1989,333(8638).
[12]P. R. EVANS,Y.-T. BAK,J. E. KELLOW.Effects of oral cisapride on small bowel motility in irritable bowel syndrome[J].1997,11(5).
[13]C, Niederau,S, Faber,M, Karaus.Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.[J].1992,102.
[14]Liu, J.-H.,Chen, G.-H.,Yeh, H.-Z.,etc.Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: A prospective, randomized trial[J].1997,32(6).
[15]Mangel, A. W.,Northcutt, A. R..Review article: the safety arid efficacy of alosetron, a 5-HT<sub>3</sub> receptor antagonist, in female irritable bowel syndrome patients.[J].1999,13.
[16]L A, Houghton,N A, Jackson,P J, Whorwell,etc.5-HT4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit.[J].1999,13(11).
[17]A, Bensoussan,N J, Talley,M, Hing,etc.Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.[J].1998,280.
[18]D, Gill,S, Hatcher.Antidepressants for depression in people with physical illness.[J].2000,(2).
[19]Pelosini I,Scarpignato C.Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.[J].1999,13(Suppl.A).
[20]J E, Lennard-Jones.Clinical management of constipation.[J].1993,47 Suppl 1.
[21]杨云生,张万岱,潘德寿,等.肠易激综合征血浆及乙状结肠粘膜中CCK及SP的含量[J].1997,(7).
[22]徐耀传.肠易激综合征124例[J].1997,(7).
[23]Pearson RL.How effective are antidepressant medications in the treatment of irritable bowel syndrome and nonulcer dyspepsia?[J].2000,49(5).
[24]E, Guthrie,F, Creed,D, Dawson,etc.A controlled trial of psychological treatment for the irritable bowel syndrome.[J].1991,100.
[25]M.H. Pittler,E. Ernst.Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis[J].1998,93(7).
[26]Johann Hammer,Nicholas J Talley.Diagnostic criteria for the irritable bowel syndrome[J].1999,107(Supplement 1).
[27]M. Delvaux,D. Louvel,J.-P. Mamet,etc.Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome[J].1998,12(9).
[28]J S, Feine,M C, Bushnell,D, Miron,etc.Sex differences in the perception of noxious heat stimuli.[J].1991,44.
[29]Goa KL,Balfour JA,Perry CM.Alosetron.[J].2000,59(3).
[30]Wu Min-Sheng,Fu Min,Weng Hui-Liang.Investigation of emotional disturbance in patients with functional gastrointestinal disorders[J].1998.
[31]Francis Creed.The relationship between psychosocial parameters and outcome in irritable bowel syndrome[J].1999,107(Supplement 1).
[32]N J, Talley,B K, Owen,P, Boyce,etc.Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials.[J].1996,91.
[33]J, Alderman.Managing irritable bowel syndrome.[J].1999,7(1).
[34]Perry CM,Scott LJ.Tegaserod.[J].1999,58(3).
[35]R H, Jones,G, Holtmann,L, Rodrigo,etc.Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients.[J].1999,13(11).
[36]R A, Awad,V H, Cordova,M, Dibildox,etc.Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome.[J].1997,27.
[37]N J, Talley.Irritable bowel syndrome: definition, diagnosis and epidemiology.[J].1999,13(3).
[38].Reaching a consensus on irritable bowel syndrome.[J].1999,161(10).
[39]S, Evangelista.Otilonium bromide: a selective spasmolytic for the gastrointestinal tract.[J].1900,27(5).
[40]K A, Gwee.The many faces of irritable bowel syndrome.[J].1999,40.
[41]M T, Romero,R J, Bodnar.Gender differences in two forms of cold-water swim analgesia.[J].1986,37(6).
[42]YANG Zhang-Shan,LIU Wan-Xi,QUO Xiao-Ling,etc.Domperidone improves galladder emptying function in patients with irritable bowei syndrome[J].1995,1(1).
[43]R E, Clouse.Antidepressants for functional gastrointestinal syndromes.[J].1994,39(11).
[44]曹斌,葛政举,孟宪镛,等.肠易激综合征结肠粘膜超微结构的观察[J].1994,(4).
[45]S S, Hegde,R M, Eglen.Peripheral 5-HT4 receptors.[J].1996,10(12).
[46]Schutze K,Brandstatter G,Dragosics B,etc.Double-blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome.[J].1997,11(2).
[47]Wallis RM..Pre-Clinical and Clinical Pharmacology of Selective Muscarinic M(3) Receptor Antagonists[J].1995,56(11).
[48]Su X,Gebhart GF.Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon.[J].1998,76(1).
[49]W G Thompson,G F Longstreth,D A Drossman,etc.Functional bowel disorders and functional abdominal pain[J].1999,45(suppl 2).
[50]H C, Wong,J K, Wong,N Y, Wong.Chinese herbal medicine for irritable bowel syndrome.[J].1999,282.
[51]Lynda R. Wiseman,Diana Faulds.Cisapride[J].1994,47(1).